Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
  • 2024-01-31T06:36:47

Dapagliflozin (5mg), Vildagliptin SR (50mg) DAPA VILDA 50/5 Dapagliflozin and Vildagliptin SR (Sustained Release) are oral antidiabetic medications used in the management of type 2 diabetes mellitus. They belong to different classes of drugs and work in different ways to control blood sugar levels: Dapagliflozin: Class: It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Mechanism of Action: Dapagliflozin works by blocking the SGLT2 protein in the kidneys. This protein normally reabsorbs glucose back into the bloodstream as the blood is filtered through the kidneys. By blocking this protein, dapagliflozin causes more glucose to be removed from the body through urine, thus lowering blood sugar levels. Use: It's used not only to improve glycemic control in type 2 diabetes but also to reduce the risk of hospitalization for heart failure in patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors.Vildagliptin SR (Sustained Release): Class: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Mechanism of Action: It works by increasing the amount of incretin available in the body. Incretins are hormones that increase insulin release in response to meals and decrease the amount of sugar the liver makes. By doing so, vildagliptin helps to control blood sugar levels. Use: It's primarily used to improve blood sugar control in adults with type 2 diabetes. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/dapa-vilda-50-5-134374

Dapagliflozin (5mg), Vildagliptin SR (50mg) DAPA VILDA 50/5 Dapagliflozin and Vildagliptin SR (Sustained Release) are oral antidiabetic medications used in the management of type 2 diabetes mellitus. They belong to different classes of drugs and work in different ways to control blood sugar levels: Dapagliflozin: Class: It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Mechanism of Action: Dapagliflozin works by blocking the SGLT2 protein in the kidneys. This protein normally reabsorbs glucose back into the bloodstream as the blood is filtered through the kidneys. By blocking this protein, dapagliflozin causes more glucose to be removed from the body through urine, thus lowering blood sugar levels. Use: It's used not only to improve glycemic control in type 2 diabetes but also to reduce the risk of hospitalization for heart failure in patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors.Vildagliptin SR (Sustained Release): Class: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Mechanism of Action: It works by increasing the amount of incretin available in the body. Incretins are hormones that increase insulin release in response to meals and decrease the amount of sugar the liver makes. By doing so, vildagliptin helps to control blood sugar levels. Use: It's primarily used to improve blood sugar control in adults with type 2 diabetes. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/dapa-vilda-50-5-134374

  • 2024-01-31T06:36:47

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us